AKCA - Akcea Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $5.71. This is a potential upside of $5.71 (0%) from yesterday's end of day stock price of $0.

Akcea Therapeutics's activity chart (see below) currently has 23 price targets and 18 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 63.75% with an average time for these price targets to be met of 27.25 days.

Most recent stock forecast was given by DO KIM from PIPER SANDLER on 01-Sep-2020. First documented stock forecast 08-Aug-2017.

Best performing analysts who are covering AKCA - Akcea Therapeutics:

Do Kim Jim Birchenough Paul Matteis Stephen Willey

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

30

3 years 8 months 21 days ago

2/8 (25%)

$14.76 (96.85%)

30

Hold

20

$1.83 (10.07%)

31

4 years 16 days ago

2/4 (50%)

$0.93 (13.82%)

13

Hold

24

$5.83 (32.09%)

33

4 years 7 months 29 days ago

4/5 (80%)

$5.96 (33.04%)

39

Hold

5 years 7 months 27 days ago

2/2 (100%)

$1.2 (5.04%)

27

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AKCA (Akcea Therapeutics) average time for price targets to be met?

On average it took 27.25 days on average for the stock forecasts to be realized with a an average price target met ratio 63.75

Which analyst has the current highest performing score on AKCA (Akcea Therapeutics) with a proven track record?

DO KIM

Which analyst has the current lower performing score on AKCA (Akcea Therapeutics) with a proven track record?

STEPHEN WILLEY

Which analyst has the most public recommendations on AKCA (Akcea Therapeutics)?

Do Kim has 44 price targets and 26 ratings on AKCA

Which analyst is the currently most bullish on AKCA (Akcea Therapeutics)?

Jim Birchenough with highest potential upside - $5.83

Which analyst is the currently most reserved on AKCA (Akcea Therapeutics)?

Do Kim with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?